Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,884,770
+$13,714,335 QoQ
Shares Held
113,733
+83.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#608
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $166,003,072 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
282,635 | $36,318,597 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
113,733 | $28,884,770 | |
| 3 | LLY |
ELI LILLY & Co
|
21,997 | $26,383,863 | |
| 4 | AMGN |
Amgen Inc
|
63,607 | $23,033,366 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
369,878 | $21,312,370 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
138,734 | $17,527,653 | |
| 7 | ABBV |
AbbVie Inc.
|
42,182 | $10,614,678 | |
| 8 | PFE |
Pfizer Inc
|
61,912 | $1,490,840 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,884,770 | 113,733 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,170,435 | 62,062 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,107,777 | 126,155 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,130,624 | 151,713 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,348,364 | 87,387 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $12,232,524 | 73,761 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,758,331 | 60,561 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,871,560 | 60,913 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,541,670 | 78,966 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,298,635 | 90,389 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,982,622 | 108,349 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,818,989 | 95,146 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,552,733 | 106,046 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $15,757,145 | 101,659 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,889,350 | 39,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,375,680 | 88,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,894,057 | 67,005 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,731,099 | 60,549 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,792,067 | 45,549 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,398,961 | 45,814 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,563,872 | 45,914 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $15,012,714 | 91,346 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,003,567 | 44,501 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,763,022 | 45,426 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $6,756,005 | 48,041 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,109,745 | 31,341 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||